JNGLX
Price
$67.24
Change
+$0.25 (+0.37%)
Updated
Jul 25 closing price
Net Assets
4.4B
SWHFX
Price
$23.94
Change
+$0.10 (+0.42%)
Updated
Jul 25 closing price
Net Assets
644.14M
Interact to see
Advertisement

JNGLX vs SWHFX

Header iconJNGLX vs SWHFX Comparison
Open Charts JNGLX vs SWHFXBanner chart's image
Janus Henderson Global Life Sciences D
Price$67.24
Change+$0.25 (+0.37%)
VolumeN/A
Net Assets4.4B
Schwab Health Care
Price$23.94
Change+$0.10 (+0.42%)
VolumeN/A
Net Assets644.14M
JNGLX vs SWHFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. SWHFX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and SWHFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. SWHFX (644M). SWHFX pays higher dividends than JNGLX: SWHFX (0.70) vs JNGLX (0.36). JNGLX was incepted earlier than SWHFX: JNGLX (27 years) vs SWHFX (25 years). JNGLX (0.80) and SWHFX (0.79) have similar cost to investors . SWHFX is a more actively managed with annual turnover of: 64.00 vs. JNGLX (35.00). SWHFX has a lower initial minimum investment than JNGLX: SWHFX (0) vs JNGLX (2500). JNGLX (-14.43) and SWHFX (-14.45) have marching annual gain over last year. JNGLX return over 5 years is better than : 4.98 vs. SWHFX (-9.56).
JNGLXSWHFXJNGLX / SWHFX
Total Expense Ratio0.800.79101%
Annual Report Gross Expense Ratio0.800.79101%
Fund Existence27 years25 years-
Gain YTD-1.3262.626-50%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B644M684%
Annual Yield % from dividends0.360.7051%
Returns for 1 year-14.43-14.45100%
Returns for 3 years8.83-7.99-110%
Returns for 5 years4.98-9.56-52%
Returns for 10 years6.80-14.56-47%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BAFMX18.34N/A
N/A
Brown Advisory Mid-Cap Growth Instl
GHTMX15.40N/A
N/A
Goldman Sachs International T/M Eq Instl
MSGFX33.43N/A
N/A
Morgan Stanley Inst Global Franchise C
JGTUX43.90N/A
N/A
JPMorgan Growth Advantage R4
TRMNX22.61N/A
N/A
T. Rowe Price Mid-Cap Index